Print Icon
 
   
   

R&D tax relief – An update on the upcoming changes

On November 30th 2022 the House of Commons debated the Finance Bill 2022-23 including the proposed changes to the R&D tax relief rates. This has recently received much press coverage, most notably the reduction in tax relief for SMEs. 

Despite debating proposed amendments that required the Government to publish:
  • An assessment on their view of the effectiveness of R&D tax reliefs for SMEs and the intention for further reform.
  • A statement on error and fraud in the SME R&D tax reliefs, including details of what actions they have taken in response including the number of investigations, prosecutions and how much reclaimed, 
the Bill passed unchanged for the R&D tax relief proposals.

However, Victoria Atkins MP, Financial Secretary to the Treasury, responded to various MP’s concerns with “I hope that we will be able to resolve those concerns working with the bio industry, the Federation of Small Businesses and other R&D-intensive small businesses ahead of the Budget in the spring”. Indeed, she confirmed meetings and round table discussions with affected sectors including the life sciences industry.

To recap, the Bill’s changes propose the following:

With effect for expenditure incurred on or after 1 April 2023:
  • RDEC increases to a taxable credit of 20% from 13%. 
    • So for £10,000 of qualifying expenditure the net credit increases from £1,053 to £1,500.
  • SME R&D tax relief additional deduction in calculating profits of trade reduced from 130% to 86%. 
    • For every £10,000 of qualifying expenditure, the tax saving reduces from £2,470 to between £1,634 (19% tax payer) to £2,150 (25% tax payer).
  • SME surrenderable loss – surrender at 10% instead of 14.5%. 
    • This reduces the maximum amount of cash refund by almost half from £3,335 for every £10,000 of qualifying expenditure to £1,860.

So, it seems that the lower rates of SME tax relief are here to stay. However, the Government has at least acknowledged the concerns of the genuine R&D companies, for whom the R&D tax relief is intended to support and incentivise. Another case of watch this space for further updates.


James Cowper Kreston’s Business Tax team work with many science and technology companies, assisting them with their R&D tax relief claims and we are constantly monitoring the progress of all the proposed changes.  It is important that companies  who claim R&D tax relief consider the impact of these changes on their future plans and what they can do to mitigate them.

We have recently released other news items relating to the changes being introduced for the R&D tax relief schemes. We will also be shortly publishing a short webinar on the changes. Please see below for more information...

     

R&D tax relief changes: Autumn Statement

Whilst still committing to increased spend on Innovation and R&D in total, the Autumn Statement announced further reforms to the R&D tax reliefs schemes.  A “rebalancing” of the schemes so that the R&D Expenditure Credit Scheme (RDEC), generally claimed by larger companies, becomes more generous, but the SME scheme, becomes less so. 

Our Autumn Statement booklet 2022

Our Autumn Statement Report provides an overview of the key announcements arising from the Chancellor's speech. Throughout the summary you will find informative comments to help you assess the effect that the proposed changes may have on you personally.


 

     
Contact Us

James Cowper Kreston is a leading firm of accountants and business advisers, with offices across the South of England. We deliver focused, innovative advice to a diverse range of businesses and individuals helping our clients to maximise their potential.

 

If you would like to discuss any of the topics raised within this newsletter above, please contact our Business Tax team who are happy to help guide you through all the forthcoming changes.


Margaret Savory


E: msavory@jamescowper.co.uk

T:  +44 (0)7823 353597

     
   

The information in this newsletter must not be relied on as giving sufficient advice in any specific case.   

   
   
Twitter
LinkedIn
Youtube
Email